CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5598.12M
Enterprise Value 3313.81M
Trailing P/E N/A
Forward P/E 1-5.19
PEG Ratio (5 yr expected) 1-0.30
Price/Sales (ttm)6.02
Price/Book (mrq)3.39
Enterprise Value/Revenue 33.16
Enterprise Value/EBITDA 6-31.28

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin -14.52%
Operating Margin (ttm)-11.36%
Management Effectiveness
Return on Assets (ttm)-3.16%
Return on Equity (ttm)-12.90%
Income Statement
Revenue (ttm)99.39M
Revenue Per Share (ttm)2.33
Quarterly Revenue Growth (yoy)-47.40%
Gross Profit (ttm)106.41M
EBITDA -10.03M
Net Income Avi to Common (ttm)-14.43M
Diluted EPS (ttm)-0.34
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)312.05M
Total Cash Per Share (mrq)5.82
Total Debt (mrq)30.16M
Total Debt/Equity (mrq)17.23
Current Ratio (mrq)10.21
Book Value Per Share (mrq)3.27
Cash Flow Statement
Operating Cash Flow (ttm)13.5M
Levered Free Cash Flow (ttm)-7.52M

Trading Information

Stock Price History
Beta 1.87
52-Week Change 34.42%
S&P500 52-Week Change 317.06%
52 Week High 317.20
52 Week Low 39.80
50-Day Moving Average 313.76
200-Day Moving Average 313.79
Share Statistics
Avg Vol (3 month) 3485.54k
Avg Vol (10 day) 3932.4k
Shares Outstanding 553.88M
Float 51.41M
% Held by Insiders 19.74%
% Held by Institutions 175.05%
Shares Short 32.69M
Short Ratio 37.34
Short % of Float 38.70%
Shares Short (prior month) 32.67M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/6
Last Split Date 3Jun 25, 2013